123 related articles for article (PubMed ID: 32889248)
1. Higher gestational weight gain and lower serum estradiol levels are associated with increased risk of preeclampsia after in vitro fertilization.
Chen YC; Lai YJ; Su YT; Tsai NC; Lan KC
Pregnancy Hypertens; 2020 Oct; 22():126-131. PubMed ID: 32889248
[TBL] [Abstract][Full Text] [Related]
2. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
3. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization.
Imudia AN; Awonuga AO; Doyle JO; Kaimal AJ; Wright DL; Toth TL; Styer AK
Fertil Steril; 2012 Jun; 97(6):1374-9. PubMed ID: 22494926
[TBL] [Abstract][Full Text] [Related]
4. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
[TBL] [Abstract][Full Text] [Related]
5. Association between serum oestradiol level on the hCG administration day and neonatal birthweight after IVF-ET among 3659 singleton live births.
Liu Y; Li J; Zhang W; Guo Y
Sci Rep; 2021 Mar; 11(1):6084. PubMed ID: 33727635
[TBL] [Abstract][Full Text] [Related]
6. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.
Huang R; Fang C; Wang N; Li L; Yi Y; Liang X
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():177-82. PubMed ID: 24862918
[TBL] [Abstract][Full Text] [Related]
7. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
8. Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology?
Royster GD; Krishnamoorthy K; Csokmay JM; Yauger BJ; Chason RJ; DeCherney AH; Wolff EF; Hill MJ
Fertil Steril; 2016 Aug; 106(2):363-370.e3. PubMed ID: 27172401
[TBL] [Abstract][Full Text] [Related]
9. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
[TBL] [Abstract][Full Text] [Related]
10. Does the estradiol level on the day of human chorionic gonadotropin administration predict the clinical outcome of controlled ovarian hyperstimulation?
Erzincan SG; Esmer AC; Baysal B
Clin Exp Obstet Gynecol; 2014; 41(6):709-12. PubMed ID: 25551969
[TBL] [Abstract][Full Text] [Related]
11. Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles.
Pereira N; Reichman DE; Goldschlag DE; Lekovich JP; Rosenwaks Z
J Assist Reprod Genet; 2015 Apr; 32(4):527-32. PubMed ID: 25682115
[TBL] [Abstract][Full Text] [Related]
12. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
14. High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth.
Hu XL; Feng C; Lin XH; Zhong ZX; Zhu YM; Lv PP; Lv M; Meng Y; Zhang D; Lu XE; Jin F; Sheng JZ; Xu J; Huang HF
J Clin Endocrinol Metab; 2014 Jun; 99(6):2217-24. PubMed ID: 24606075
[TBL] [Abstract][Full Text] [Related]
15. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
[TBL] [Abstract][Full Text] [Related]
16. Association of serum estradiol levels on the day of hCG administration with pregnancy rates and embryo scores in fresh ICSI/ET cycles down regulated with either GnRH agonists or GnRH antagonists.
Taşkin EA; Atabekoğlu CS; Musali N; Öztuna D; Sönmezer M
Arch Gynecol Obstet; 2014 Feb; 289(2):399-405. PubMed ID: 23912535
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with extremely high progesterone concentrations on the day of HCG administration.
Tsai YR; Lin YJ; Lin YC; Hsu TY; Lan KC
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101720. PubMed ID: 32113001
[TBL] [Abstract][Full Text] [Related]
18. Effect of elevated estradiol levels on the hCG administration day on IVF pregnancy and birth outcomes in the long GnRH-agonist protocol: analysis of 3393 cycles.
Wang M; Hao C; Bao H; Huang X; Liu Z; Zhang W; Li F
Arch Gynecol Obstet; 2017 Feb; 295(2):407-414. PubMed ID: 27858152
[TBL] [Abstract][Full Text] [Related]
19. The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.
Cicek MN; Kahyaoglu I; Kahyaoglu S
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):539-44. PubMed ID: 25753867
[TBL] [Abstract][Full Text] [Related]
20. The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles.
Huang CY; Shieh ML; Li HY
J Chin Med Assoc; 2016 Jul; 79(7):387-93. PubMed ID: 27147462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
